RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF. (Q51053038)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2013

Language	Label	Description	Also known as
English	RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.	scientific article published in August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

1 reference

based on heuristic

inferred from title

author name string

A Krause

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

W Z Whu

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

J Qiu

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

D Wafadari

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

N R Hackett

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

A Sharma

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

R G Crystal

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

S Worgall

8

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

173

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

230-241

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

Vaccines and immunotherapy against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Pseudomonas immunotherapy: a historical overview

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Pseudomonas aeruginosa: the potential to immunise against infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Recent developments for Pseudomonas vaccines

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Outer Membrane Proteins of Pseudomonas aeruginosa Serotype Strains

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Recognition of host immune activation by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Neutralizing antibodies against 33 human adenoviruses in normal children in Rome

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Development of nonhuman adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Novel adenovirus vector-based vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

New insights on adenovirus as vaccine vectors

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Vaccination strategies to promote mucosal antibody responses.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

An evaluation of respiratory administration of measles vaccine for prevention of acute lower respiratory infections in children

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Intrapleural administration of a serotype 5 adeno-associated virus coding for alpha1-antitrypsin mediates persistent, high lung and serum levels of alpha1-antitrypsin

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Protection against pulmonary infection with Pseudomonas aeruginosa following immunization with P. aeruginosa-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenovirus vector-mediated gene transfer to regional lymph nodes

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Lung dendritic cells at the innate-adaptive immune interface

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naïve and antigen-primed T cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Intracellular trafficking of adenovirus: many means to many ends

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Cystic fibrosis: a mucosal immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Lung infections associated with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Comparative biology of cystic fibrosis animal models

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12101

21 January 2018

Delivery of antigens by viral vectors for vaccination.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Intrapleural 'outside-in' gene therapy: therapeutics for organs of the chest via gene transfer to the pleura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Circumventing the immune response to adenovirus-mediated gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3722923

2 November 2018

Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of antimicrobial resistance in bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sublingual administration of an adenovirus serotype 5 (Ad5)-based vaccine confirms Toll-like receptor agonist activity in the oral cavity and elicits improved mucosal and systemic cell-mediated responses against HIV antigens despite preexisting Ad5 i

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular immune responses of healthy individuals to intradermal administration of an E1-E3- adenovirus gene transfer vector

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children

1 reference

https://pubmed.ncbi.nlm.nih.gov/23607394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CEI.12101

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/23607394

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51053038&oldid=1418429572"